Tag: morbidity and mortality

Study results evidence long-term effectiveness of gastric bypass surgery

Editor's Note Roux-en-Y gastric bypass surgery kept type 2 diabetes in remission for up to 15 years and maintained most of the weight loss for up to 20 years in a long-term study, according to a June 12 report in SciTech Daily. Presented the same day at The American Society…

Read More

By: Matt Danford
June 20, 2024
Share

Study: Infection risk unaffected by colonoscopy, joint replacement timing

JAMA (healthcare publication) Network logo

Editor's Note A study published May 7 in JAMA Open found no significant risk of periprosthetic joint infection (PJI) when colonoscopy is performed within one year of total joint arthroplasty (TJA), whether the colonoscopy was done before or after the surgery. However, certain comorbidities such as kidney and pulmonary disease,…

Read More

By: Matt Danford
May 28, 2024
Share

Study: Ozempic slows disease, reduces cardiovascular risk in CKD, diabetes patients

Editor's Note Semaglutide, the active ingredient in Ozempic diabetes treatment and Wegovy weight-loss treatment, outperformed a placebo and demonstrated capacity to reduce risk of death from kidney-related or cardiovascular causes in a recent study of patients with type 2 diabetes and chronic kidney disease spearheaded by manufacturer Novo Nordisk. Published…

Read More

By: Matt Danford
May 28, 2024
Share

Heart disease trial supports less-invasive alternative to SAVR, CABG surgery

Editor's Note Contrary to previous findings, less-invasive percutaneous intervention combining fractional flow reserve (FFR)-guided percutaneous coronary intervention (PCI) with transcatheter aortic valve replacement (TAVR) could be a viable alternative to surgery for patients with severe aortic stenosis (AS) and concomitant obstructive coronary artery disease (CAD). That’s according to the results…

Read More

By: Matt Danford
May 23, 2024
Share

FDA announces class 1 recall for radiographic breast tissue marker

Editor's Note The US Food and Drug Administration (FDA) has designated the recall of Hologic Inc.’s BioZorb Marker a class 1, indicating a risk of serious injury or death. BioZorb is an implantable radiographic marker used to mark soft tissue (such as breast tissue) for future medical procedures. Provided sterile…

Read More

By: Matt Danford
May 23, 2024
Share

Study: Surgical team diversity improves patient outcomes

Editor's Note The more diverse the surgical team, the better the outcomes for patients and the lower the cost of care, according to a study of more than 700,000 operations at 88 hospitals in Ontario, Canada. Published May 15 in the British Journal of Surgery, findings show that surgeon-anesthetist teams…

Read More

By: Matt Danford
May 15, 2024
Share

Premature mortality rates higher for lesbian, bisexual female nurses

JAMA (healthcare publication) Network logo

Editor's Note Sexual orientation has a significant impact on all-cause mortality rates among female nurses, according to a study published April 25 in Jama. The prospective cohort study focused on 90,833 women initially recruited in 1989 for Nurses’ Health Study II whose sexual orientation had been identified in 1995. Of…

Read More

By: Matt Danford
May 7, 2024
Share

FDA Class 1 recall renews concern about historically problematic heart pumps

The US Food & Drug Administration (FDA) announced a Class 1 recall on Monday for Abbott/Thoratec Corp.’s HeartMate II and HeartMate 3 Left Ventricular Assist System (LVAS) due due to biological material buildup obstructing the devices. According to an April 16 CBS News report, surgeons first noticed problems with the…

Read More

By: Matt Danford
April 17, 2024
Share

Study recommends against polyhexanide wound irrigation during open abdominal surgery

Editor's Note Although intraoperative wound irrigation is a common practice worldwide for preventing surgical site infections, a recent study suggests irrigation with polyhexanide solution should not be recommended as standard clinical practice in open clean-contaminated surgical procedures. Published February 21 in Jama Surgery, the study cautions that additional trials are…

Read More

By: Matt Danford
March 28, 2024
Share

Bioelectric mesh could help track cardiac disease

Editor's Note Although cardiac disease is the leading cause of human morbidity and mortality globally, the complexity of cardiac tissues makes monitoring difficult. To address this issue, a team from University of Massachusetts Amherst and MIT has created a bioelectronic mesh system that can measure movement of cells in cardiac…

Read More

By: Brita Belli
March 27, 2024
Share
Live chat by BoldChat